Publications by authors named "Jason Gee"

Claim this Profile
E
Endovascular Downstaging: A New Method for Managing Renal Cell Carcinoma Tumor Thrombus Invading the Inferior Vena Cava Above the Hepatic Veins (Level III) or into the Heart (Level IV).
John A Libertino, Malik Ahmed, Thomas Piemonte, Jason Gee

Cancers (Basel)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in standing stability with balance-based torso-weighting with cerebellar ataxia: A pilot study.
Gail L Widener, Nicole Conley, Sarah Whiteford, Jason Gee, Anthony Harrell

Physiother Res Int· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Randomized, Double-blind, Presurgical Trial of Polyphenon E in Bladder Cancer Patients to Evaluate Pharmacodynamics and Bladder Tissue Biomarkers.
Jason R Gee, Daniel R Saltzstein, KyungMann Kim, Jill Kolesar, Wei Huang

Cancer Prev Res (Phila)· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA Expression Profile Identifies High Grade, Non-Muscle-Invasive Bladder Tumors at Elevated Risk to Progress to an Invasive Phenotype.
Sara M Lenherr, Sheaumei Tsai, Brasil Silva Neto, Travis B Sullivan, Cara B Cimmino, Jason Gee

Genes (Basel)· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomy.
Jason R Gee, Daniel R Saltzstein, Edward Messing, KyungMann Kim, Jill Kolesar

Eur J Cancer Prev· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soy food frequency questionnaire does not correlate with baseline isoflavone levels in patients with bladder cancer.
Jill M Kolesar, Marcia Pomplun, Tom Havighurst, Jeanne Stublaski, Barbara Wollmer, Jason Gee

J Oncol Pharm Pract· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsies.
Alan W Partin, Leander Van Neste, Eric A Klein, Leonard S Marks, Jason R Gee

J Urol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Underutilization of immediate intravesical chemotherapy following TURBT: results from NSQIP.
Casey Kowalik, Jason R Gee, Andrea Sorcini, Alireza Moinzadeh, David Canes

Can J Urol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-specific activation of an EGFR-targeting probody enhances therapeutic index.
Luc R Desnoyers, Olga Vasiljeva, Jennifer H Richardson, Annie Yang, Elizabeth E M Menendez, Jason Gee

Sci Transl Med· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II open label, multi-center clinical trial of modulation of intermediate endpoint biomarkers by 1α-hydroxyvitamin D2 in patients with clinically localized prostate cancer and high grade pin.
Jason Gee, Howard Bailey, Kyungmann Kim, Jill Kolesar, Tom Havighurst

Prostate· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, diagnosis, and molecular markers.
Ashish M Kamat, Paul K Hegarty, Jason R Gee, Peter E Clark, Robert S Svatek

Eur Urol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The extracytoplasmic function sigma factor EcfO protects Bacteroides fragilis against oxidative stress.
Ivan C Ndamukong, Jason Gee, C Jeffrey Smith

J Bacteriol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of endoplasmic reticulum stress genes, BiP and chop, in genetic and environmental models of retinal degeneration.
Heike Kroeger, Carissa Messah, Kelly Ahern, Jason Gee, Victory Joseph

Invest Ophthalmol Vis Sci· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SodA is a major metabolic antioxidant in Brucella abortus 2308 that plays a significant, but limited, role in the virulence of this strain in the mouse model.
Daniel W Martin, John E Baumgartner, Jason M Gee, Eric S Anderson, R Martin Roop

Microbiology (Reading)· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patients.
Edward Messing, Jason R Gee, Daniel R Saltzstein, KyungMann Kim, Anthony diSant'Agnese

Cancer Prev Res (Phila)· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-dimensional replica exchange approach for peptide-peptide interactions.
Jason Gee, M Scott Shell

J Chem Phys· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Bayesian adaptive design with biomarkers for targeted therapies.
Jens C Eickhoff, KyungMann Kim, Jason Beach, Jill M Kolesar, Jason R Gee

Clin Trials· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BCAN Think Tank session 3: Prevention of bladder cancer.
Seth P Lerner, H Barton Grossman, Edward M Messing, Adam S Kibel, Andrew Stephenson, Jason R Gee

Urol Oncol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of 15-hydroxyprostaglandin dehydrogenase expression contributes to bladder cancer progression.
Stephanie Tseng-Rogenski, Jason Gee, Kathleen Woods Ignatoski, Lakshmi P Kunju, Amanda Bucheit

Am J Pathol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclin-mediated G1 arrest by celecoxib differs in low-versus high-grade bladder cancer.
Jason R Gee, Corrie B Burmeister, Thomas C Havighurst, Kyungmann Kim

Anticancer Res· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flexible and rigid cystoscopy in women.
Jason R Gee, Bradley J Waterman, David F Jarrard, Sean P Hedican, Reginald C Bruskewitz

JSLS· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to antiangiogenesis therapy in a patient with advanced adult-type testicular granulosa cell tumor.
Michael R Harrison, Wei Huang, Glenn Liu, Jason Gee

Oncology (Williston Park)· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Grade and stage at presentation do not predict mortality in patients with bladder cancer who survive their disease.
Edward M Messing, Ralph Madeb, Changyong Feng, Laura Stephenson, Kennedy W Gilchrist, Jason Gee

J Clin Oncol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced bladder cancer recurrence rate with cardioprotective aspirin after intravesical bacille Calmette-Guérin.
Jason R Gee, David F Jarrard, Reginald C Bruskewitz, Timothy D Moon, Sean P Hedican

BJU Int· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Forced COX-2 expression induces PGE(2) and invasion in immortalized urothelial cells.
Jason Gee, I-Ling Lee, H Barton Grossman, Anita L Sabichi

Urol Oncol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis